Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TRICOR
- Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
- Fenofibrate and Propranolol in Burn Patients
- Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
- Lipid Biomarkers for Diabetic Heart Disease
- The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers
- Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
- Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)
- Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)
- Triglyceride Lowering Study
- The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
- Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels
- Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions
- Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions
- Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol
- Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
- Effect of a Fibrate and a Statin on Endothelial Dysfunction
- Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
- Obesity and Nonalcoholic Fatty Liver Disease
- Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
- A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
- Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Clinical trials list
click for details